The global GMP cell banking market is expected to grow at a CAGR of 7.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing demand for biologics and biosimilars in the pharmaceutical industry. Biologics are biological products that are produced using living organisms or their components, such as proteins, cells, or tissues. They are used for treating various diseases and conditions such as cancer, arthritis, diabetes mellitus type 1 and 2 etc, which has led to an increase in demand for GMP cell banks across the globe.
Mammalian Cell segment is expected to dominate the global GMP cell banking market during the forecast period due to its high demand in biopharmaceutical companies and contract manufacturing organizations across North America and Europe regions. Microbial Cell segment is expected to witness fastest growth rate during the forecast period due to its high demand in Asia Pacific region owing to increasing number of biopharmaceutical companies operating there.
Some Of The Growth Factors Of This Market:
- Increasing demand for stem cells and regenerative medicine products.
- Increasing number of clinical trials in the field of regenerative medicine.
- Growing awareness about the benefits of stem cell therapy.
- Increase in government funding for research and development.
Industry Growth Insights published a new data on “GMP Cell Banking Market”. The research report is titled “GMP Cell Banking Market research by Types (Mammalian Cell, Microbial Cell, Insect Cell, Others), By Applications (Biopharmaceutical Companies, Contract Manufacturing Organizations), By Players/Companies WuXi AppTec, Charles River Laboratories International, Inc., Eurofins Scientific, Merck KGaA, Lonza Group Ltd, SGS Ltd, ViruSure GmbH, Austrianova, Goodwin Biotechnology Inc., Paragon Bioservices, Inc.”.
Scope Of The Report
Report Attributes
Report Details
Report Title
GMP Cell Banking Market Research Report
By Type
Mammalian Cell, Microbial Cell, Insect Cell, Others
By Application
Biopharmaceutical Companies, Contract Manufacturing Organizations
By Companies
WuXi AppTec, Charles River Laboratories International, Inc., Eurofins Scientific, Merck KGaA, Lonza Group Ltd, SGS Ltd, ViruSure GmbH, Austrianova, Goodwin Biotechnology Inc., Paragon Bioservices, Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global GMP Cell Banking Market Report Segments:
The global GMP Cell Banking market is segmented on the basis of:
Types
Mammalian Cell, Microbial Cell, Insect Cell, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Biopharmaceutical Companies, Contract Manufacturing Organizations
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- WuXi AppTec
- Charles River Laboratories International, Inc.
- Eurofins Scientific
- Merck KGaA
- Lonza Group Ltd
- SGS Ltd
- ViruSure GmbH
- Austrianova
- Goodwin Biotechnology Inc.
- Paragon Bioservices, Inc.
Highlights of The GMP Cell Banking Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Mammalian Cell
- Microbial Cell
- Insect Cell
- Others
- By Application:
- Biopharmaceutical Companies
- Contract Manufacturing Organizations
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the GMP Cell Banking Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
GMP Cell Banking is a process where banks collect and store cells from patients who have had surgery. These cells can be used to help researchers develop new treatments for diseases.
Some of the major players in the gmp cell banking market are WuXi AppTec, Charles River Laboratories International, Inc., Eurofins Scientific, Merck KGaA, Lonza Group Ltd, SGS Ltd, ViruSure GmbH, Austrianova, Goodwin Biotechnology Inc., Paragon Bioservices, Inc..
The gmp cell banking market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. GMP Cell Banking Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. GMP Cell Banking Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. GMP Cell Banking Market - Supply Chain
4.5. Global GMP Cell Banking Market Forecast
4.5.1. GMP Cell Banking Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. GMP Cell Banking Market Size (000 Units) and Y-o-Y Growth
4.5.3. GMP Cell Banking Market Absolute $ Opportunity
5. Global GMP Cell Banking Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. GMP Cell Banking Market Size and Volume Forecast by Type
5.3.1. Mammalian Cell
5.3.2. Microbial Cell
5.3.3. Insect Cell
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global GMP Cell Banking Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. GMP Cell Banking Market Size and Volume Forecast by Application
6.3.1. Biopharmaceutical Companies
6.3.2. Contract Manufacturing Organizations
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global GMP Cell Banking Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. GMP Cell Banking Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global GMP Cell Banking Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. GMP Cell Banking Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global GMP Cell Banking Demand Share Forecast, 2019-2029
9. North America GMP Cell Banking Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America GMP Cell Banking Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America GMP Cell Banking Market Size and Volume Forecast by Application
9.4.1. Biopharmaceutical Companies
9.4.2. Contract Manufacturing Organizations
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America GMP Cell Banking Market Size and Volume Forecast by Type
9.7.1. Mammalian Cell
9.7.2. Microbial Cell
9.7.3. Insect Cell
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America GMP Cell Banking Demand Share Forecast, 2019-2029
10. Latin America GMP Cell Banking Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America GMP Cell Banking Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America GMP Cell Banking Market Size and Volume Forecast by Application
10.4.1. Biopharmaceutical Companies
10.4.2. Contract Manufacturing Organizations
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America GMP Cell Banking Market Size and Volume Forecast by Type
10.7.1. Mammalian Cell
10.7.2. Microbial Cell
10.7.3. Insect Cell
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America GMP Cell Banking Demand Share Forecast, 2019-2029
11. Europe GMP Cell Banking Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe GMP Cell Banking Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe GMP Cell Banking Market Size and Volume Forecast by Application
11.4.1. Biopharmaceutical Companies
11.4.2. Contract Manufacturing Organizations
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe GMP Cell Banking Market Size and Volume Forecast by Type
11.7.1. Mammalian Cell
11.7.2. Microbial Cell
11.7.3. Insect Cell
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Marke Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe GMP Cell Banking Demand Share, 2019-2029
12. Asia Pacific GMP Cell Banking Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific GMP Cell Banking Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific GMP Cell Banking Market Size and Volume Forecast by Application
12.4.1. Biopharmaceutical Companies
12.4.2. Contract Manufacturing Organizations
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific GMP Cell Banking Market Size and Volume Forecast by Type
12.7.1. Mammalian Cell
12.7.2. Microbial Cell
12.7.3. Insect Cell
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific GMP Cell Banking Demand Share, 2019-2029
13. Middle East & Africa GMP Cell Banking Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa GMP Cell Banking Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa GMP Cell Banking Market Size and Volume Forecast by Application
13.4.1. Biopharmaceutical Companies
13.4.2. Contract Manufacturing Organizations
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa GMP Cell Banking Market Size and Volume Forecast by Type
13.7.1. Mammalian Cell
13.7.2. Microbial Cell
13.7.3. Insect Cell
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa GMP Cell Banking Demand Share, 2019-2029
14. Competition Landscape
14.1. Global GMP Cell Banking Market: Market Share Analysis
14.2. GMP Cell Banking Distributors and Customers
14.3. GMP Cell Banking Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. WuXi AppTec
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Charles River Laboratories International, Inc.
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Eurofins Scientific
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Merck KGaA
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Lonza Group Ltd
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. SGS Ltd
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. ViruSure GmbH
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Austrianova
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Goodwin Biotechnology Inc.
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Paragon Bioservices, Inc.
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
